A detailed history of Cerity Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Cerity Partners LLC holds 60,050 shares of DXCM stock, worth $4.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
60,050
Previous 20,706 190.01%
Holding current value
$4.82 Million
Previous $2.35 Million 71.45%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $2.52 Million - $4.57 Million
39,344 Added 190.01%
60,050 $4.02 Million
Q2 2024

Aug 13, 2024

SELL
$110.31 - $140.45 $615,309 - $783,430
-5,578 Reduced 21.22%
20,706 $2.35 Million
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $50 Million - $61.3 Million
-437,689 Reduced 94.34%
26,284 $3.65 Million
Q4 2023

Jan 26, 2024

BUY
$75.49 - $124.16 $34.4 Million - $56.6 Million
456,097 Added 5790.97%
463,973 $57.6 Million
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $749,152 - $1.2 Million
-8,705 Reduced 52.5%
7,876 $734,000
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $413,102 - $481,089
3,673 Added 28.46%
16,581 $2.13 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $16,120 - $19,052
155 Added 1.22%
12,908 $1.5 Million
Q4 2022

Feb 15, 2023

BUY
$84.98 - $122.67 $453,623 - $654,812
5,338 Added 71.99%
12,753 $1.44 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $21,988 - $27,123
-288 Reduced 3.74%
7,415 $597,000
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $425,277 - $831,226
6,255 Added 431.98%
7,703 $575,000
Q1 2022

Apr 25, 2022

SELL
$94.08 - $130.2 $52,872 - $73,172
-562 Reduced 27.96%
1,448 $743,000
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $84,675 - $106,158
652 Added 48.01%
2,010 $1.08 Million
Q3 2021

Oct 25, 2021

SELL
$106.71 - $143.18 $3,521 - $4,724
-33 Reduced 2.37%
1,358 $743,000
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $1,295 - $1,726
16 Added 1.16%
1,391 $594,000
Q1 2021

Aug 11, 2021

BUY
$84.79 - $104.74 $84 - $104
1 Added 0.07%
1,375 $494,000
Q1 2021

May 12, 2021

BUY
$84.79 - $104.74 $14,583 - $18,015
172 Added 14.31%
1,374 $494,000
Q4 2020

Feb 11, 2021

BUY
$78.0 - $104.5 $702 - $940
9 Added 0.75%
1,202 $444,000
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $32,664 - $38,628
342 Added 40.19%
1,193 $492,000
Q2 2020

Aug 14, 2020

SELL
$62.68 - $105.34 $6,644 - $11,166
-106 Reduced 11.08%
851 $345,000
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $334 - $529
7 Added 0.74%
957 $258,000
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $34,789 - $54,425
950 New
950 $208,000
Q1 2019

May 14, 2019

SELL
$28.07 - $38.18 $67,311 - $91,555
-2,398 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$26.99 - $37.37 $26,450 - $36,622
980 Added 69.11%
2,398 $287,000
Q3 2018

Nov 15, 2018

BUY
$23.35 - $36.72 $33,110 - $52,068
1,418 New
1,418 $203,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.